147 related articles for article (PubMed ID: 10775792)
21. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.
Granoff DM; Holmes SJ; Belshe RB; Osterholm MT; McHugh JE; Anderson EL
JAMA; 1994 Oct; 272(14):1116-21. PubMed ID: 7933324
[TBL] [Abstract][Full Text] [Related]
22. Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines.
Granoff DM; Rathore MH; Holmes SJ; Granoff PD; Lucas AH
Vaccine; 1993; 11 Suppl 1():S46-51. PubMed ID: 8447176
[TBL] [Abstract][Full Text] [Related]
23. Immunologic priming by one dose of Haemophilus influenzae type b conjugate vaccine in infancy.
Kurikka S; Käyhty H; Saarinen L; Rönnberg PR; Eskola J; Mäkelä PH
J Infect Dis; 1995 Nov; 172(5):1268-72. PubMed ID: 7594663
[TBL] [Abstract][Full Text] [Related]
24. The immunogenicity of three Haemophilus influenzae type B conjugate vaccines after a primary vaccination series in Philippine infants.
Capeding MR; Nohynek H; Pascual LG; Kayhty H; Sombrero LT; Eskola J; Ruutu P
Am J Trop Med Hyg; 1996 Nov; 55(5):516-20. PubMed ID: 8940983
[TBL] [Abstract][Full Text] [Related]
25. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.
Hu JL; Tao H; Li JX; Dai WM; Song B; Sun JF; Liu P; Tang J; Liu WY; Wang SY; Zhu FC
Hum Vaccin Immunother; 2015; 11(5):1120-8. PubMed ID: 25833163
[TBL] [Abstract][Full Text] [Related]
26. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.
Lottenbach KR; Granoff DM; Barenkamp SJ; Powers DC; Kennedy D; Irby-Moore S; Homan SM; Mink CM
J Am Geriatr Soc; 2004 Nov; 52(11):1883-7. PubMed ID: 15507066
[TBL] [Abstract][Full Text] [Related]
27. Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
Weinberg GA; Einhorn MS; Lenoir AA; Granoff PD; Granoff DM
J Pediatr; 1987 Jul; 111(1):22-7. PubMed ID: 3110388
[TBL] [Abstract][Full Text] [Related]
28. Haemophilus influenzae type b conjugate vaccines: a review of efficacy data.
Heath PT
Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S117-22. PubMed ID: 9781743
[TBL] [Abstract][Full Text] [Related]
29. Transplacental antibody transfer following maternal immunization with polysaccharide and conjugate Haemophilus influenzae type b vaccines.
Englund JA; Glezen WP; Turner C; Harvey J; Thompson C; Siber GR
J Infect Dis; 1995 Jan; 171(1):99-105. PubMed ID: 7798688
[TBL] [Abstract][Full Text] [Related]
30. Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants.
Bulkow LR; Wainwright RB; Letson GW; Chang SJ; Ward JI
Pediatr Infect Dis J; 1993 Jun; 12(6):484-92. PubMed ID: 8345981
[TBL] [Abstract][Full Text] [Related]
31. Antibody response of Navajo children primed with PRP-OMP vaccine to booster doses of PRP-OMP vs. HbOC vaccine.
Reid R; Santosham M; Croll J; Thompson C; Newcomer W; Siber GR
Pediatr Infect Dis J; 1993 Oct; 12(10):812-5. PubMed ID: 8284116
[TBL] [Abstract][Full Text] [Related]
32. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants.
Chotpitayasunondh T; Panpitpat C; Thisyakorn U; Furer E; Que JU; Hasler T; Cryz SJ
Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):91-8. PubMed ID: 9322290
[TBL] [Abstract][Full Text] [Related]
33. Dose-related immunogenicity of Haemophilus influenzae type b capsular polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
Wong VK; Quagliata R; Adler R; Kim KS
Am J Dis Child; 1991 Jul; 145(7):742-5. PubMed ID: 2058604
[TBL] [Abstract][Full Text] [Related]
34. The effectiveness of Haemophilus influenzae type b conjugate vaccines in a high risk population measured using immunization register data.
Markey P; Krause V; Boslego JW; Coplan PM; Dargan JM; Kaplan KM
Epidemiol Infect; 2001 Feb; 126(1):31-6. PubMed ID: 11293680
[TBL] [Abstract][Full Text] [Related]
35. Haemophilus influenzae type b-specific antibody in infants after maternal immunization.
Englund JA; Glezen WP; Thompson C; Anwaruddin R; Turner CS; Siber GR
Pediatr Infect Dis J; 1997 Dec; 16(12):1122-30. PubMed ID: 9427456
[TBL] [Abstract][Full Text] [Related]
36. Anti-polyribosyl-ribitol phosphate and anti-N. meningitidis outer membrane protein antibody levels following PRP-OMP conjugate vaccination.
Wong VK; Kim KS
Vaccine; 1993; 11(9):979-80. PubMed ID: 8212847
[No Abstract] [Full Text] [Related]
37. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
Sood SK; Daum RS
Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
[TBL] [Abstract][Full Text] [Related]
38. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB): clinical evaluation.
Ahonkhai VI; Lukacs LJ; Jonas LC; Matthews H; Vella PP; Ellis RW; Staub JM; Dolan KT; Rusk CM; Calandra GB
Pediatrics; 1990 Apr; 85(4 Pt 2):676-81. PubMed ID: 2107518
[TBL] [Abstract][Full Text] [Related]
39. Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease.
Walter EB; Moggio MV; Drucker RP; Wilfert CM
Pediatr Infect Dis J; 1990 Sep; 9(9):632-5. PubMed ID: 2235187
[TBL] [Abstract][Full Text] [Related]
40. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.
Schlesinger Y; Granoff DM
JAMA; 1992 Mar; 267(11):1489-94. PubMed ID: 1538539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
